Lin Xu

Lin Xu

Auto-generated profile, based on publicly available information

Lin Xu

State Key Laboratory of Oral Diseases, National Center for Stomatology, National Clinical Research Center for Oral Diseases, Department of Orthodontics, West China Hospital of Stomatology, Sichuan University, Chengdu, 610041, China

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2024 in Bioactive Materials
Verified
Journal Article
Open access
LXLin Xu
Lin Xu
JFJie Fang
Jie Fang
JPJiezhou Pan
Jiezhou Pan
HQHexu Qi
Hexu Qi
YYYun Yin
Yun Yin
JGJunling Guo
Junling Guo
Orthopedic and dental implantations under bacterial infection microenvironment face significant challenges in achieving high-quality bone-implant integration. Designing implant coatings that incorporate both immune defense and anti-inflammation is difficult in conventional single-functional coatings. We introduce a multifunctional nanointerface using a zinc finger-inspired peptide-metal-phenolic nanocoating, designed to enhance implant osseointegration under such conditions. Abaloparatide (ABL), a second-generation anabolic drug for treating osteoporosis, can be integrated into the design of a zinc-phenolic network constructed on the implant surface (ABL@ZnTA). Importantly, the phenolic-coordinated Zn2+ ions in ABL@ZnTA can act as zinc finger motif to co-stabilize the configuration of ABL through multiple molecular interactions, enabling high bioactivity, high loading capacity (1.36 times), and long-term release (>7 days) of ABL. Our results showed that ABL@ZnTA can modulate macrophage polarization from the pro-inflammatory M1 towards the anti-inflammatory M2 phenotype, promoting immune osteogenesis with increased OCN, ALP, and SOD 1 expression. Furthermore, the ABL@ZnTA significantly reduces inflammatory fibrous tissue encapsulation and enhances the long-term stability of the implants, indicated by enhanced binding strength (6 times) and functional connectivity (1.5-3 times) in the rat bone defect model infected by S. aureus. Overall, our research offers a nano-enabled synergistic strategy that balances infection defense and osteogenesis promotion in orthopedic and dental implantations.

1 April 2012 in Hepatogastroenterology
Verified
Journal Article
Closed access
LXLin Xu
Lin Xu
MXMing-Qing Xu
Ming-Qing Xu
LYLu-Nan Yan
Lu-Nan Yan
BLBo Li
Bo Li
TWTianfu Wen
Tianfu Wen
WWWenTao Wang
WenTao Wang
To analyze the causes of death, both in the short- and long-term after cadaveric liver transplantation (LT) from a single center in mainland China. Clinical data of 472 adult patients who underwent primary cadaveric LT from February 1999 to December 2009 at our center were identified. All patients were followed-up until December 2010. Mortalities in three periods were described: the postoperative mortality (within the first 90 postoperative days or more if the patient remained hospitalized); the early mortality (death between 4-12 months after transplantation); the late mortality (death after one year following transplantation). The survival of the 472 patients at 3 months, 1, 3 and 5 years was 85.2%, 73.5%, 61.2% and 59.7%, respectively. The postoperative mortality, the early mortality and the late mortality were 34.8% (70/201), 27.4% (55/201) and 37.8% (76/201), respectively. Infection, multi-organ failure and technical complications were the major causes of death during the first period, and the recurrence of malignancy was the main cause of death during the early and late periods after LT. Recurrence of malignancy was the major cause of the early and late mortality in our study, which is higher than that of other reports. The serious preoperative condition of the recipient, the waiting timing for the operation and the tumor selection criteria for LT may account for this.

25 July 2022 in The Korean Journal of Orthodontics
Verified
Journal Article
Open access
PDF file
LXLin Xu
Lin Xu
LMLi Mei
Li Mei
RLRuiqi Lu
Ruiqi Lu
YLYuan Li
Yuan Li
HLHanshi Li
Hanshi Li
YLYu Li
Yu Li
Lin Xu, Li Mei, Ruiqi Lu, Yuan Li, Hanshi Li, Yu Li. Korean J Orthod 2022;52:268-77. https://doi.org/10.4041/kjod21.255

1 January 2020 in Journal of Applied Oral Science
Verified
Journal Article
Open access
PDF file
LXLin Xu
Lin Xu
LMLi Mei
Li Mei
RZRui Zhao
Rui Zhao
JYJianru Yi
Jianru Yi
YJYixuan Jiang
Yixuan Jiang
YLYu Li
Yu Li
Objective To investigate the effects of intro-oral injection of parathyroid hormone (PTH) on tooth extraction wound healing in hyperglycemic rats. Methodology 60 male Sprague-Dawley rats were randomly divided into the normal group (n=30) and DM group (n=30). Type 1 diabetes mellitus (DM) was induced by streptozotocin. After extracting the left first molar of all rats, each group was further divided into 3 subgroups (n=10 per subgroup), receiving the administration of intermittent PTH, continuous PTH and saline (control), respectively. The intermittent-PTH group received intra-oral injection of PTH three times per week for two weeks. A thermosensitive controlled-release hydrogel was synthesized for continuous-PTH administration. The serum chemistry was determined to evaluate the systemic condition. All animals were sacrificed after 14 days. Micro-computed tomography (Micro-CT) and histological analyses were used to evaluate the healing of extraction sockets. Results The level of serum glucose in the DM groups was significantly higher than that in the non-DM groups (p0.05). Micro-CT analysis showed that the DM group had a significantly lower alveolar bone trabecular number (Tb.N) and higher trabecular separation (Tb.Sp) than the normal group (p0.05). Conclusions Bone formation in the extraction socket of the type 1 diabetic rats was reduced. PTH did not improve the healing of hard and soft tissues. The different PTH administration regimes (continuous vs. intermittent) had similar effect on tissue healing. These results demonstrated that the metabolic characteristics of the hyperglycemic rats produced a condition that was unable to respond to PTH treatment.